The Impact of Comparative Effectiveness Research on the Pharmaceutical Industry

The Impact of Comparative Effectiveness Research ...

New federal funding for healthcare reform has cast a spotlight on comparative effectiveness research (CER).


Related content

By selecting ‘winners or losers’ among different therapeutic alternatives, CER programs will have a considerable impact on pharmaceutical companies in terms of R&D, product development, profit margins, market focus and many other factors. At the same time, CER can represent a strategic opportunity for companies to develop a patient-centric business model designed to increase their competitive advantage and position themselves for future growth.

Connect with us


Request for proposal



KPMG's new digital platform

KPMG International has created a state of the art digital platform that enhances your experience, optimized to discover new and related content.